The SLC34A3 gene hypophosphatemic rickets with hypercalciuria (HHRH) genetic test is a specialized diagnostic assessment offered at DNA Labs UAE. This test is designed to identify mutations in the SLC34A3 gene, which are responsible for HHRH, a rare inherited disorder characterized by low levels of phosphate in the blood (hypophosphatemia), leading to weak and soft bones (rickets), alongside an unusually high level of calcium in the urine (hypercalciuria). This condition contrasts with other forms of rickets, primarily through its unique combination of hypophosphatemia and hypercalciuria, making accurate genetic testing crucial for proper diagnosis and treatment.
The test is conducted through a detailed analysis of the patient's DNA, looking specifically for mutations in the SLC34A3 gene that are known to cause the disorder. By identifying these mutations, healthcare providers can confirm a diagnosis of HHRH, enabling them to tailor a treatment plan that addresses both the phosphate and calcium imbalances in the body. This may include dietary adjustments, supplements, or other medications designed to manage the symptoms and prevent complications.
The cost of the SLC34A3 gene hypophosphatemic rickets with hypercalciuria genetic test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test and the comprehensive analysis required to accurately identify the SLC34A3 gene mutations. Patients or their guardians considering this test are advised to consult with their healthcare provider to discuss its potential benefits and implications for treatment planning.
The FGF23 Gene Hypophosphatemic Rickets Autosomal Dominant Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the FGF23 gene, which are associated with a form of hypophosphatemic rickets that follows an autosomal dominant inheritance pattern. Hypophosphatemic rickets is a disorder characterized by low levels of phosphate in the blood, leading to weak and soft bones, among other symptoms. The FGF23 gene plays a crucial role in phosphate homeostasis, and mutations in this gene can disrupt phosphate metabolism, resulting in the condition.
This genetic test is crucial for the accurate diagnosis and management of individuals showing symptoms suggestive of hypophosphatemic rickets, as well as for the identification of carriers within affected families. Early diagnosis can lead to timely intervention, potentially improving outcomes and quality of life for those affected.
The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed. Opting for this test at DNA Labs UAE ensures that patients and their families receive comprehensive support, from the initial consultation through to the interpretation of results and guidance on the next steps.
The DMP1 gene, responsible for coding the dentin matrix acidic phosphoprotein 1, plays a critical role in bone mineralization and phosphate homeostasis. Mutations in the DMP1 gene can lead to Hypophosphatemic Rickets, specifically autosomal recessive type 1, a rare genetic disorder characterized by low phosphate levels in the blood due to impaired phosphate reabsorption in the kidneys. This condition results in weak and soft bones, leading to bone pain, deformities, and frequent fractures.
The genetic test for DMP1 gene mutations is a crucial diagnostic tool for confirming the presence of Hypophosphatemic Rickets autosomal recessive type 1. This test involves analyzing the patient's DNA to identify mutations in the DMP1 gene that are known to cause the disorder. Early and accurate diagnosis through genetic testing can facilitate timely intervention and management of the condition, improving the quality of life for affected individuals.
In the UAE, this specialized genetic test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The test cost is set at 4400 AED. DNA Labs UAE employs state-of-the-art technology and methodologies to ensure high accuracy and reliability of the test results, providing crucial information for the management and treatment of patients with Hypophosphatemic Rickets autosomal recessive type 1.
The COL11A2 gene plays a crucial role in the development and maintenance of the body's connective tissues. Mutations in this gene can lead to a condition known as fibrochondrogenesis 2, a rare genetic disorder characterized by skeletal abnormalities, short stature, and other connective tissue issues. The genetic test for fibrochondrogenesis 2 focuses on identifying mutations in the COL11A2 gene to confirm a diagnosis, which is vital for managing the condition and understanding the risk of passing it on to future generations.
At DNA Labs UAE, individuals can undergo the COL11A2 gene fibrochondrogenesis 2 genetic test. The test is conducted with high precision and accuracy, providing essential information for affected families. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the comprehensive insights it offers into this specific genetic condition. This testing service is an invaluable resource for families seeking answers about fibrochondrogenesis 2, offering them a clear path towards understanding and managing the condition.
The COL11A1 gene plays a crucial role in the development and maintenance of the body's connective tissues, including cartilage, bones, and other vital structures. Mutations in the COL11A1 gene can lead to fibrochondrogenesis type 1, a rare genetic disorder characterized by skeletal abnormalities, short stature, and other connective tissue issues. To diagnose this condition, genetic testing is essential.
At DNA Labs UAE, a specialized genetic test targeting the COL11A1 gene is offered to identify mutations associated with fibrochondrogenesis type 1. This test is crucial for confirming the diagnosis, understanding the condition's severity, and guiding treatment and management decisions. The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific genetic alterations in the COL11A1 gene.
Early diagnosis through genetic testing can significantly impact the management of fibrochondrogenesis type 1, enabling tailored care and interventions that improve the quality of life for affected individuals.
The ACVR1 Gene Fibrodysplasia Ossificans Progressiva (FOP) Genetic Test is a specialized diagnostic examination conducted to identify mutations in the ACVR1 gene, which are indicative of Fibrodysplasia Ossificans Progressiva (FOP). FOP is a rare and severe genetic disorder characterized by the abnormal development of bone in muscles, tendons, and other connective tissues, leading to significant physical disability over time. This condition is primarily caused by mutations in the ACVR1 gene, which plays a crucial role in bone growth and development.
The test is aimed at individuals who exhibit symptoms of FOP or have a family history of the condition, providing a crucial tool for early diagnosis and management. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the ACVR1 gene to detect mutations associated with FOP.
The cost of the ACVR1 Gene Fibrodysplasia Ossificans Progressiva Genetic Test at DNA Labs UAE is 4400 AED. The test is a valuable investment for affected families, offering insights into the genetic basis of FOP and facilitating informed decisions about management and care. Early and accurate diagnosis through this test can significantly impact the quality of life of individuals with FOP, providing a pathway to tailored treatments and interventions.
The "PHOX2A Gene Fibrosis of Extraocular Muscles Congenital Type 2 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the PHOX2A gene, which are associated with the rare genetic condition known as Congenital Fibrosis of the Extraocular Muscles Type 2 (CFEOM2). This condition primarily affects the muscles that control eye movement, leading to restricted eye movement and, in some cases, ptosis (drooping of the upper eyelid), which can significantly impact vision and quality of life.
The test is particularly important for individuals showing symptoms of CFEOM2 or those with a family history of the condition, as it can provide a definitive diagnosis. Early detection through genetic testing is crucial for managing the condition, allowing for timely intervention and support strategies to improve patient outcomes.
Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and stringent quality standards, the test ensures high accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting that accompanies the testing process.
By opting for this genetic test, patients and their families can gain valuable insights into their genetic makeup, paving the way for personalized medical approaches and informed decision-making regarding treatment options and lifestyle adjustments to accommodate the condition.
The SRCAP Gene Floating-Harbor Syndrome Genetic Test is a specific diagnostic tool used to identify mutations in the SRCAP gene, which are linked to Floating-Harbor syndrome. This rare genetic disorder is characterized by short stature, delayed bone age, distinctive facial features, and speech and language difficulties. The test is crucial for confirming the diagnosis, allowing for a better understanding of the condition and facilitating tailored management and treatment plans for affected individuals.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, this test involves analyzing the patient's DNA to look for specific mutations in the SRCAP gene that are associated with the syndrome. The process is comprehensive, ensuring high accuracy and reliability in the results.
The cost of the SRCAP Gene Floating-Harbor Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis and the provision of a comprehensive report, which is essential for healthcare providers to make informed decisions about the patient's care. Given the complexity of genetic testing and the expertise required to interpret the results, this price reflects the value of obtaining a precise diagnosis and the potential to significantly impact the patient's quality of life through personalized treatment strategies.
Focal Dermal Hypoplasia, also known as Goltz syndrome, is a rare genetic disorder that affects the development of various body systems including the skin, skeletal system, eyes, and in some cases, the face and teeth. The PORCN gene plays a crucial role in this condition, as mutations in this gene are responsible for the manifestations of the syndrome. The PORCN gene is vital for the proper development of the ectoderm, the embryonic layer from which the skin, eyes, and certain other tissues are derived.
To diagnose this condition accurately, genetic testing for mutations in the PORCN gene is essential. In the UAE, DNA Labs offers a specialized genetic test designed to detect mutations in the PORCN gene that are associated with Focal Dermal Hypoplasia. This test is crucial for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding management and treatment plans.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any mutations in the PORCN gene. The cost of the PORCN gene genetic test at DNA Labs UAE is 4400 AED. This investment not only provides a definitive diagnosis but also contributes to a better understanding of the condition, which can be invaluable for affected individuals and their families in managing the syndrome and making informed decisions about their health and future.
The SH3PXD2B gene plays a crucial role in the development of Frank-ter Haar syndrome, a rare genetic disorder characterized by skeletal, cardiac, and eye abnormalities. To diagnose this condition, a genetic test focusing on the SH3PXD2B gene can be performed. This test is available at DNA Labs UAE, a leading facility in genetic diagnostics.
The genetic test for Frank-ter Haar syndrome involves analyzing the patient's DNA to identify mutations in the SH3PXD2B gene that are indicative of the disorder. This is crucial for confirming the diagnosis, understanding the disease's progression, and making informed decisions about treatment and management.
The cost of the SH3PXD2B gene test for Frank-ter Haar syndrome at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the specific genetic alterations associated with the syndrome. Given the complexity and the specialized technology involved in genetic testing, the cost reflects the extensive resources utilized to ensure accurate and reliable results.
Overall, this genetic test is a vital tool for individuals suspected of having Frank-ter Haar syndrome, providing them with crucial information for managing their condition.
